Back to FDA Applications sponsored by DAIICHI SANKYO

FDA Drug Application 206316 by DAIICHI SANKYO

Application Number206316
Application Type New Drug Application
Sponsor ApplicantDAIICHI SANKYO
Most Recent Label Available Flag
Current Patent Flag
Action Type Approval
Chemical Type New molecular entity (NME)
Therapeutic Potential Standard
Orphan Code 

Action TypeDuplicate CounterAction DateDocument TypeApplication Document IDSequence NumberDocument TitleDocument URLDocument Date
AP01/8/2015N43124000 1/9/2015
AP11/8/2015N43124000 1/9/2015
AP01/8/2015N43125000 1/9/2015
AP11/8/2015N43125000 1/9/2015
AP01/8/2015N43126000 2/13/2015
AP11/8/2015N43126000 2/13/2015
AP01/8/2015N43127000 2/13/2015
AP11/8/2015N43127000 2/13/2015
AP01/8/2015N43128000 1/9/2015
AP11/8/2015N43128000 1/9/2015
AP01/8/2015N43129000 1/9/2015
AP11/8/2015N43129000 1/9/2015
AP01/8/2015N43130000 2/13/2015
AP11/8/2015N43130000 2/13/2015
AP01/8/2015N43131000 2/13/2015
AP11/8/2015N43131000 2/13/2015
AP09/10/2015SLR43849002 9/11/2015
AP09/10/2015SLR43859002 9/14/2015
AP09/15/2016SLR47070004 9/19/2016
AP09/15/2016SLR47098004 9/20/2016
AP010/16/2015SCM44280006 10/23/2015

Back to FDA Applications sponsored by DAIICHI SANKYO

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer

Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.